Click on the links below to read some informative studies about the effects of CMO on arthritis conducted by some of the country's top medical institutions.
A COMPREHENSIVE PERSPECTIVE OF CMO AS AN ADAPTAGENIC IMMUNOMODULATOR
The report on these two pages is reprinted with the permission of its author, Dr. Len Sands. Dr Sands is the Director of the San Diego International Immunological Center and developer of the originial CMO oral formula.
SAN DIEGO CLINIC: THE FIRST TRIALS
An informal human study was undertaken at a facility called the San Diego Clinic in late 1995. It was conducted by Dr. Len Sands, Ph.D.
CMO TESTING BY MEDISURE
Medisure supplied sufficient IMUNALL (brand of CMO) to Advanced Medical Systems & Design, Ltd. for a two year field study on the effectiveness of their "natural nutritional compound", Cerasomal-cis-9-cetylmyristoleate (CMO), which had after earlier research and testing by Medisure, shown to be effective in relieving the adverse symptoms of arthritis and perhaps other immune system disorders.
A RANDOMIZED CLINICAL TRIAL
The effect of cetyl myristoleate and adjunctive therapy on the course of arthritic episodes in patients with various auto-immune diseases characterized by the common terminology, "arthritis" and "psoriasis".